We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential enable/disable

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name	Webedition CMS
Purpose	This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.

External media enable/disable

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name	YouTube
Purpose	Show YouTube content
Name	Twitter
Purpose	activate Twitter Feeds

Research

HI-TRON Mainz Research Group mRNA Cancer Immunotherapies

Prof. Dr. Ugur Sahin

The Sahin research group conducts research on "mRNA cancer immunotherapies", including antigen-specific immunotherapies using both antibody- and T-cell-based approaches. In addition to classical laboratory techniques, the focus is on sequencing techniques and bioinformatics methods. The aim is - in line with the philosophy of HI-TRON Mainz - to promote the rapid transfer of laboratory research into the clinic.

Contact

Prof. Dr. Ugur Sahin

mRNA Cancer Immunotherapies (D194)

Helmholtz Institute for Translational Oncology Mainz (HI-TRON Mainz) - A Helmholtz Institute by DKFZ
Obere Zahlbacherstr. 63
Building 911
55131 Mainz

E-Mail: ugur.sahin (at) dkfz-heidelberg.de